{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:56:23Z","timestamp":1793670983408,"version":"4.5.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/aog.0000000000001136","type":"journal-article","created":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T18:40:33Z","timestamp":1454784033000},"page":"459-467","source":"Crossref","is-referenced-by-count":22,"title":["Cervical Cancer Screening"],"prefix":"10.1097","volume":"127","author":[{"given":"George F.","family":"Sawaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Smith-McCune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20211128","first-page":"e1","article-title":"Practice Bulletin No. 157. American College of Obstetricians and Gynecologists.","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R2-6-20211128","first-page":"1338","article-title":"Practice Bulletin No. 140. American College of Obstetricians and Gynecologists.","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R3-6-20211128","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMcp1210379","article-title":"Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting.","volume":"369","author":"Schiffman","year":"2013","journal-title":"N Engl J Med"},{"key":"R5-6-20211128","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/01.AOG.0000120143.50098.c7","article-title":"Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more.","volume":"103","author":"Goldie","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"suppl 1","key":"R6-6-20211128","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcv.2004.12.008","article-title":"The epidemiology of human papillomavirus infections.","volume":"32","author":"Baseman","year":"2005","journal-title":"J Clin Virol"},{"key":"R8-6-20211128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":". American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R10-6-20211128","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/M14-2426","article-title":"Qaseem A; Clinical Guidelines Committee of American College of Physicians. Cervical cancer screening in average-risk women: best practice advice from the Clinical Guidelines Committee of the American College of Physicians.","volume":"162","author":"Sawaya","year":"2015","journal-title":"Ann Intern Med"},{"key":"R11-6-20211128","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e3181996ffa","article-title":"Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting.","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R12-6-20211128","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":". 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R14-6-20211128","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/AOG.0000000000000287","article-title":"Treatment of cervical precancers: back to basics.","volume":"123","author":"Khan","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R15-6-20211128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis.","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"R16-6-20211128","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","article-title":". Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.","volume":"337","author":"Arbyn","year":"2008","journal-title":"BMJ"},{"key":"R17-6-20211128","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/AOG.0000000000000174","article-title":"Loop electrosurgical excision procedure and risk of preterm birth: a systematic review and meta-analysis.","volume":"123","author":"Conner","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R18-6-20211128","doi-asserted-by":"crossref","first-page":"g6192","DOI":"10.1136\/bmj.g6192","article-title":". Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis.","volume":"349","author":"Kyrgiou","year":"2014","journal-title":"BMJ"},{"key":"R21-6-20211128","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jnci\/djp089","article-title":"Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study.","volume":"101","author":"Melnikow","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R22-6-20211128","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","article-title":"Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R23-6-20211128","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/AOG.0b013e31825bc6e8","article-title":". Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.","volume":"120","author":"Grimm","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R25-6-20211128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1472-6874-10-11","article-title":"Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs A systematic review.","volume":"10","author":"Chamot","year":"2010","journal-title":"BMC Womens Health"},{"key":"R26-6-20211128","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/cncr.28548","article-title":"Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.","volume":"120","author":"Rositch","year":"2014","journal-title":"Cancer"},{"key":"R27-6-20211128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ajog.2006.02.047","article-title":"Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).","volume":"195","author":"Walker","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 1","key":"R28-6-20211128","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/LGT.0b013e31828543c5","article-title":". Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R29-6-20211128","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/AOG.0b013e3181f88e72","article-title":". Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness.","volume":"116","author":"Melnikow","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R30-6-20211128","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ajog.2008.11.031","article-title":"Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review.","volume":"200","author":"Chan","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R31-6-20211128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ygyno.2010.05.002","article-title":". Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions.","volume":"118","author":"Kuppermann","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R32-6-20211128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/LGT.0b013e3182616241","article-title":"Screening for cervical cancer: a modeling study for the US Preventive Services Task Force.","volume":"17","author":"Kulasingam","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R33-6-20211128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AOG.0000000000000669","article-title":". Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.","volume":"125","author":"Huh","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R34-6-20211128","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1016\/j.vaccine.2012.07.056","article-title":"Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States.","volume":"30","author":"Chesson","year":"2012","journal-title":"Vaccine"},{"key":"R35-6-20211128","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/LGT.0b013e31829c97d8","article-title":". The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance.","volume":"18","author":"Sharp","year":"2014","journal-title":"J Low Genit Tract Dis"},{"key":"R36-6-20211128","doi-asserted-by":"crossref","first-page":"107497","DOI":"10.1155\/2011\/107497","article-title":"Socioeconomic, Rural-Urban, and Racial Inequalities in US Cancer Mortality: Part IAll Cancers and Lung Cancer and Part IIColorectal, Prostate, Breast, and Cervical Cancers.","volume":"2011","author":"Singh","year":"2011","journal-title":"J Cancer Epidemiol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201603000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T15:00:33Z","timestamp":1638111633000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201603000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001136","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}